Soligenix, Inc. (NASDAQ: SNGX) has been gaining investor attention as a late-stage biopharmaceutical company focused on developing and commercializing treatments across oncology, rare diseases, and biodefense. For small-cap investors, SNGX stands out because of its pipeline maturity and government partnerships, both of which can serve as strong catalysts for long-term value creation.

Luxury skiwear and lifestyle brand Perfect Moment Ltd. (PMNT) reported fiscal Q1 2026 results showing revenue up 51% year over year to $1.5 million and a record gross margin of 60.4%. Shares jumped sharply in early trading following the release. Yahoo FinanceChartMill

Why AACIW matters today: Armada Acquisition Corp. II (Nasdaq: AACIW) is the public warrant tied to SPAC Armada Acquisition Corp. II. Units from Armada’s $230M IPO began trading separately on June 24, 2025—shares as AACI and warrants as AACIW—putting the levered instrument on screens for event-driven investors.

180 Life Sciences Corp., doing business as ETHZilla, disclosed holdings of 82,186 Ether (ETH) acquired at an average price of $3,806.71, valued at approximately $349 million, alongside roughly $238 million in USD cash equivalents.

La Jolla, California — Equillium, Inc. (NASDAQ: EQ), the clinical-stage biotech innovator, has secured a significant financing package, raising up to $50 million to fast-track its next-generation therapy, EQ504, into the clinic. MarketWatch+13equilliumbio.com+13Investing.com+13